![Pulsed Electromagnetic Fields for Clinical Applications](http://img.images-bn.com/static/redesign/srcs/images/grey-box.png?v11.9.4)
Pulsed Electromagnetic Fields for Clinical Applications
280![Pulsed Electromagnetic Fields for Clinical Applications](http://img.images-bn.com/static/redesign/srcs/images/grey-box.png?v11.9.4)
Pulsed Electromagnetic Fields for Clinical Applications
280Paperback
-
PICK UP IN STORECheck Availability at Nearby Stores
Available within 2 business hours
Related collections and offers
Overview
In perspective, this modality provides a practical, exogenous method for inducing cell and tissue modification attempted to the injured tissues to their normal physiological status. The book reviews the current state of equipment for PEMFs and highlights worldwide therapeutic achievements.
- It explores the past, present, and future of PEMF therapies.
- It presents the development of theory and laboratory research during the last 70 years.
- It reviews the available equipment for PEMF.
- It reviews the state of the art of worldwide therapeutic achievements.
- It includes recent achievements and applications of electroporation modalities.
Product Details
ISBN-13: | 9781032653822 |
---|---|
Publisher: | CRC Press |
Publication date: | 10/02/2023 |
Pages: | 280 |
Product dimensions: | 6.12(w) x 9.19(h) x (d) |
About the Author
Jim Ryaby, PhD joined Orthofix as Chief Scientific Officer in July 2013 after serving as a consultant. Before joining the Company, he served as Vice President of Research and Clinical Affairs for musculoskeletal applications at Mesoblast. Dr. Ryaby has also held the position of Senior Vice President of Research and Clinical Affairs and Chief Scientific Officer at OrthoLogic Corp in Tempe, AZ. where he led the development of the CMF technology for spine fusion and nonunions and the TP508 peptide therapeutic development program in orthopedic and diabetic ulcer applications. Additionally, he has served as Adjunct Professor of Bioengineering at Arizona State University. Dr. Ryaby received his PhD degree in cellular and molecular biology from the Mt. Sinai School of Medicine, New York.
Erik I. Waldorff, PhD, is the Principal Scientist and Research Manager for the orthopedic medical device company, Orthofix, which he joined in 2012. Prior to this Dr. Waldorff served as a Clinical Research Scientist for the Neuromodulation Division at St. Jude Medical (now Abbott) where he performed pre-clinical studies in addition to post-market clinical trials for spinal cord stimulation and deep brain stimulation patients. In addition following his doctoral studies, Dr. Waldorff held a position as a Postdoctoral Fellow at the Michigan Institute for Clinical and Health Research (MICHR) at the University of Michigan where he led orthopaedic human and animal studies. Dr. Waldorff received his PhD and MSE degrees in Biomedical Engineering and MSE and BSE degrees in Aerospace Engineering from the University of Michigan (Ann Arbor, Michigan).